B Cell Signature during Inactive Systemic Lupus Erythematosus
Author Information
Author(s): Garaud Jean-Claude, Schickel Jean-Nicolas, Blaison Gilles, Knapp Anne-Marie, Dembele Doulaye, Ruer-Laventie Julie, Korganow Anne-Sophie, Martin Thierry, Soulas-Sprauel Pauline, Pasquali Jean-Louis
Primary Institution: CNRS UPR 9021, Institut de Biologie Moléculaire et Cellulaire, Strasbourg, France
Hypothesis
What are the intrinsic defects in B cells during inactive phases of systemic lupus erythematosus?
Conclusion
The study found that despite a similar lupus phenotype, different biological pathways can lead to variations in B cell behavior in lupus patients.
Supporting Evidence
- The study identified 14 differentially expressed genes in lupus B cells compared to controls.
- A subgroup of 5 lupus patients exhibited a distinct gene expression profile.
- Statistical analysis revealed significant differences in gene expression related to the endoplasmic reticulum.
- IL-4 was identified as a significant factor influencing gene expression in the subgroup of patients.
Takeaway
This study looked at B cells from lupus patients and found that even when the disease seems the same, the B cells can behave differently.
Methodology
The study analyzed the transcriptomes of purified B cells from inactive lupus patients and compared them to healthy controls using microarray technology.
Potential Biases
Potential biases may arise from the selection of patients and the inherent variability in gene expression among individuals.
Limitations
The study was limited by the small sample size and the inability to find distinct clinical differences among the patient subgroups.
Participant Demographics
17 patients (15 females, 2 males) with inactive systemic lupus erythematosus and 10 healthy controls (8 females, 2 males).
Statistical Information
P-Value
0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website